A prospective cohort study evaluating the role of quantifying sonographic inflammatory changes in GCA
VUS quantification scores performed better than other clinical variables in predicting future adverse events in GCA and OGUS is validated in a prospective cohort. These data suggest that VUS quantification scores are candidate biomarkers for GCA and may be important outcome variables in clinical trials.
Authors
- Colm Kirby (ORCID: https://orcid.org/0000-0001-7131-6721)
- Ronan Mullan (ORCID: https://orcid.org/0000-0001-5979-3680)
- Rachael Flood (ORCID: https://orcid.org/0000-0002-3347-2499)
- Gráinne Murphy (ORCID: https://orcid.org/0000-0002-7794-7724)
- Diana Gheta
- Sharon Cowley (ORCID: https://orcid.org/0000-0002-7788-8322)
- Danielle Molloy
- David Kane (ORCID: https://orcid.org/0009-0004-5460-0965)
Institutions
- Trinity College Dublin (IE)
- Cork University Hospital (IE)
- Tallaght University Hospital (IE)
Publication Details
- Journal
- Rheumatology Advances in Practice
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1093/rap/rkaf085
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Health Service Executive